Anti-BAFFR (ianalumab biosimilar) mAb

• Catalog Number: orb1173654
• Category: Antibodies
• Description: Anti-BAFFR (ianalumab biosimilar) mAb
• Target: BAFF-R
• Clonality: Monoclonal
• Species/Host: Human
• Isotype: IgG1
• Conjugation: Unconjugated
• Reactivity: Human
• Form/Appearance: Powder
• Buffer/Preservatives: Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization.
• Purification: Purified from cell culture supernatant by affinity chromatography
• UniProt ID: Q96RJ3
• Tested applications: ELISA, FC
• Dilution range: ELISA 1:5000-10000|Flow Cyt 1:100
• Application notes: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
• Antibody Type: Biosimilar Antibody
• Storage: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
• Alternative names: BAFFR;TNFRSF13C;BAFF-R;BROMIX;CD268;CVID4;prolixin
• Note: For research use only

ELISA plate pre-coated by 2 μg/ml (100 μL/well) Human BAFFR, mFc tagged protein orb689403 can bind Anti-BAFFR Neutralizing antibody (orb1173654) in a linear range of 0.64-16 ng/ml.

HEK293 cell line transfected with irrelevant protein (B) and human BAFFR (A) were surface stained with Anti-BAFFR mAb 1 μg/ml (ianalumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.